tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Stock Investors

211 Followers
Based on 728,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PHAT
On average, investors allocate 0.00% of their portfolios to PHAT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 728,786 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PHAT

<0.1%
Last 7
Days
4.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PHAT, out of 728,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PHAT Investor Activity

No data currently available
Based on the activity of 13,682 investors who made their portfolios public
The table shows changes in PHAT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PHAT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.19%
-0.88%
-3.40%
36.58B
Consumer Cyclical
ChargePoint Holdings
3.92%
-0.98%
-7.42%
592.70M
Consumer Cyclical
Riot Platforms
4.74%
-1.51%
-0.24%
2.02B
Financial
Coherus Biosciences
2.65%
-1.28%
-8.31%
244.02M
Healthcare
Merck & Company
4.12%
-0.11%
-0.79%
317.52B
Healthcare
Plug Power
4.90%
-0.90%
-6.61%
1.87B
Industrials
Marathon Digital Holdings
5.39%
-0.80%
-3.86%
4.14B
Financial
NextEra Energy
3.96%
+0.07%
-2.70%
130.92B
Utilities
Marvell
4.86%
+1.33%
+6.29%
57.57B
Technology
GE Aerospace
5.53%
+0.62%
+6.08%
170.19B
Industrials
Based on the activity of 728,786 active portfolios
Open your Smart Portfolio

PHAT Investor Analysis

PHAT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
5.9%
of PHAT holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
PHAT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
58.8%
of PHAT holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
PHAT investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
35.3%
of PHAT holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of PHAT stock investors
See who invests in PHAT according to age group and performance.

FAQ

How many retail Investors hold PHAT?
<0.1% of TipRanks' retail investors hold PHAT in their portfolios.
    What is PHAT Investor Sentiment?
    PHAT’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of PHAT in the last 7 days?
      <0.1% of TipRanks' retail investors changed their holding of PHAT in the last 7 days.
        What percentage of retail investors changed their holding of PHAT in the last 30 days?
        ▲ 4.9% of TipRanks' retail investors changed their holding of PHAT in the last 30 days.
          What is the average age of retail investors who hold PHAT?
          The average age of PHAT Holders is between 35–55.
            What other stocks have PHAT investors also bought?
            PHAT Investors also bought DKNG, CHPT, RIOT, CHRS, MRK, PLUG, MARA, NEE, MRVL, GE.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis